ICON Eyecare experiences 66% data quality improvement and 90% increase in efficiency.

Dr. James Fox of ICON Eyecare (Grand Junction, CO) discusses what it really takes to scale clinical research today. He walks through the burnout his team faced, the turning point that led to adopting AI teammates, and the measurable improvements in data quality, team capacity, and growth. He unpacks the staffing paradox in research, the trust that's at stake, and what it means for the future when AI and humans work side-by-side. His site, running 30 trials with a lean team, is a case study in what happens when AI meets the real-world pressure of clinical operations.

Transforming Clinical Trials with AI: An in-depth Discussion with Dr. David Chin YeeDr. David Chin Yee, Research Director at Georgia Retina shares his journey and the transformation of the practice with the use of AI teammates. Georgia Retina is one of the largest private practice retina groups in the Southeast. As an early adopter of AI to streamline clinical research, he discusses the integration of AI into his studies, how he's dealing with challenges of high staff turnover, and the critical role of efficient systems in improving clinical research outcomes. Learn about the future of AI in ophthalmology and the steps Dr. Chin Yee is taking to make Georgia Retina a top-tier clinical trial site.

A powerful conversation with Dr. George Magrath, CEO of Opus Genetics and seasoned ophthalmologist, as he shares how AI is reshaping clinical trials, and the incredible impact of AI teammates on his clinical research program. From cutting trial timelines to boosting enrollment, George reveals real-world wins in biotech and gene therapy for rare childhood blindness. Opus' near sci-fi levels of science is restoring vision for blind adults. Learn how AI is easing site coordinator burden, accelerating research, and making once-impossible treatments a reality.